October 12, 2020
As healthcare becomes more digitized and clinical treatments shift away from one-size-fits-all therapies, the industry will need to become more critical about how it's employing and curating health data.
For vendors and providers, it's about understanding what tools are at their disposal and how they can be implemented to maintain and improve the standard of care. But for regulators like the FDA...
August 26, 2020
Real-world evidence (RWE) technology startup Aetion has extended last year's $63 million Series B with a new $19 million raise. The funds come as strategic investments from Johnson & Johnson Innovation, JJDC, EDBI and Greenspring Associates, all three of which are new supporters of the company.
WHAT IT DOES
Founded in 2013, the company's platform provides insights from RWE to decision-makers...
December 18, 2019
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures.
WHAT THEY DO
OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...
December 5, 2019
The FDA and National Institutes of Health are tapping the clinical community and a newly launched mobile platform in its search for novel infectious disease interventions.
Called CURE ID, the online data repository will allow clinicians to report instances in which existing FDA-approved drugs are used to successfully treat infections.
In particular, the tool captures clinical outcomes in cases...
November 20, 2019
Sanofi is merging its real-world data platform with New York startup Aetion’s similar evidence platform to augment its treatment development and deployment efforts, the companies announced today. Sanofi’s DARWIN platform will provide a substantial body of de-identified patient data, which the Aetion Evidence Platform will analyze those information for insights on drug effectiveness, safety and...
July 29, 2019
Last week, Eko Devices announced a new service that matches ECG and heart sound recordings with clinical data to help pinpoint novel drug-data combinations. The Silicon Valley startup is pitching the platform, called Eko Home, as a resource for clinical trials targeting new therapies.
The new platform is already seeing some action. According to the company, an ongoing Mayo Clinic study exploring...
July 1, 2019
It would be hard to discuss healthcare trends without talking about what this means for the behemoth pharma industry. Recently, new kid on the block digital health has started to turn heads in across this well-established sector with its potential for improving R&D, tracking real-world evidence and even creating a new type of medicine with digital therapeutics.
While digital promises the...
April 9, 2019
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, Concerto announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology...
March 14, 2019
Clinical trial data analysis company TriNetX has raised $40 million in a Series D funding round led by Merck Global Health Innovation Fund. Also participating in the round were new investors Mitsui & Co. and Itochu Technology Ventures, and returning backers MPM Capital, F2 Ventures and Deerfield Management.
Announced yesterday, the new investments bring TriNetX’s total funding to $102 million...
February 19, 2019
Shimmer, a Dublin-based wearable sensor company, has launched a new sensor platform for clinical trials called VeriSense. At launch, the platform will work with Shimmer's IMU, or inertial measurement unit, sensor, which can measure activity and sleep from the wrist, as well as network with sensors elsewhere on the body to monitor musculoskeletal and neurological conditions.
The company has been...